Integrated therapy of advanced melanoma.

被引：0
|
作者：
Vitello, S
Scuderi, G
机构：
[1] Osped S Elia Caltanissetta, Serv Oncol, Caltanissetta, Italy
[2] Osped S Elia Caltanissetta, Reparto Dermatol, Caltanissetta, Italy
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
G23
引用
收藏
页码：62 / 62
页数：1
相关论文
共 50 条
  • [21] Factors predicting the use of immunotherapy for patients with advanced melanoma.
    Joseph, Richard Wayne
    Shillington, Alicia
    Macahilig, Cynthia
    Diede, Scott J.
    Dave, Vaidehi
    Harshaw, Qing
    Liu, Frank Xiaoqing
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [22] Impact of systemic therapy sequencing on overall survival for patients with advanced BRAF-mutated melanoma.
    Adi Kartolo, B.
    Deluce, Jasna
    Hopman, Wilma M.
    Liu, Linda
    Baetz, Tara D.
    Scott Ernst, D.
    Lenehan, John Gordon
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [23] Clinical characteristics predictive of response to pembrolizumab in advanced melanoma.
    Tsai, Katy K.
    Loo, Kimberly
    Khurana, Neharika
    Algazi, Alain Patrick
    Hwang, Jimmy
    Sanchez, Roberto
    Krummel, Matthew
    Rosenblum, Michael
    Tumeh, Paul
    Daud, Adil
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [24] NIVOLUMAB CLEARANCE IS TIME-VARYING IN ADVANCED MELANOMA AND STATIONARY IN ADJUVANT MELANOMA.
    Hamuro, L. L.
    Statkevich, P.
    Bello, A.
    Roy, A.
    Bajaj, G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S68 - S68
  • [25] Salvage combination ipilimumab and nivolumab after failure of prior checkpoint inhibitor therapy in patients with advanced melanoma.
    Gaughan, Elizabeth Mary
    Petroni, Gina R.
    Grosh, William W.
    Slingluff, Craig L.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [26] Using machine learning to predict immunotherapy response in advanced melanoma.
    Johannet, Paul
    Coudray, Nicolas
    Donnelly, Douglas M.
    Jour, George
    Illa-Bochaca, Irineu
    Xia, Yuhe
    Johnson, Douglas Buckner
    Wheless, Lee E.
    Patrinely, James Randall
    Pavlick, Anna C.
    Weber, Jeffrey S.
    Zhong, Hua
    Tsirigos, Aristotelis
    Osmannyu, Iman
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [27] Treatment beyond progression with immune checkpoint inhibitors in advanced melanoma.
    Sobczuk, Pawel
    Czarnecka, Anna Malgorzata
    Spalek, Mateusz
    Teterycz, Pawel
    Dudzisz-Sledz, Monika
    Switaj, Tomasz
    Rogala, Pawel
    Placzke, Joanna
    Kozak, Katarzyna
    Borkowska, Aneta
    Kosela-Paterczyk, Hanna
    Rutkowski, Piotr
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [28] A prediction model for response to immune checkpoint inhibition in advanced melanoma.
    van Duin, Isabella A. J.
    Verheijden, Rik Jasper
    van Diest, Paul J.
    van den Eertwegh, Alfonsus Johannes Maria
    de Groot, Jan Willem
    van Not, Olivier Jules
    Aarts, Maureen J. B.
    Van den Berkmortel, Franchette
    Blank, Christian U.
    Haanen, John B. A. G.
    Hospers, Geke
    Piersma, Djura
    van Rijn, Rozemarijn
    Van der Veldt, Astrid Aplonia Maria
    Vreugdenhil, Gerard
    Stevense-den Boer, Marion
    Boers-Sonderen, Marye J.
    Kapiteijn, Ellen
    Suijkerbuijk, Karijn
    Elias, Sjoerd G.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [29] Malignant head and neck melanoma. Part 2: Therapy
    Pfoehler, C.
    Vogt, T.
    Mueller, C. S. L.
    HNO, 2015, 63 (08) : 593 - 602
  • [30] The knowledge of melanoma.
    Hada, B
    VIRCHOWS ARCHIV FUR PATHOLOGISCHE ANATOMIE UND PHYSIOLOGIE UND FUR KLINISCHE MEDIZIN, 1914, 215 (02): : 216 - 232
12345